These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 3711365)

  • 21. Thrombocytopenia secondary to sulindac therapy.
    Shojania AM; Rusen SD
    Can Med Assoc J; 1981 Dec; 125(12):1313. PubMed ID: 7198933
    [No Abstract]   [Full Text] [Related]  

  • 22. Renal papillary necrosis due to naproxen.
    Caruana RJ; Semble EL
    J Rheumatol; 1984 Feb; 11(1):90-1. PubMed ID: 6699841
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sulfate homeostasis. III. Effect of chronic naproxen or sulindac treatment on inorganic sulfate disposition in arthritic patients with renal impairment.
    Morris ME; Freer JP; Watson WA
    Pharm Res; 1991 Feb; 8(2):242-6. PubMed ID: 2023875
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recurrent hyperkalemia and acute renal failure following sulindac therapy.
    Horowitz J; Sukenik S; Altz-Smith M
    Isr J Med Sci; 1988 Aug; 24(8):433-4. PubMed ID: 3410675
    [No Abstract]   [Full Text] [Related]  

  • 25. Effects of sulindac and naproxen in patients with chronic glomerular disease.
    Kamper AL; Strandgaard S; Christensen P; Svendsen UG
    Scand J Rheumatol Suppl; 1986; 62():26-31. PubMed ID: 3541165
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Side effects from sulindac (Clinoril)].
    Ugeskr Laeger; 1982 Jul; 144(27):2029. PubMed ID: 6216640
    [No Abstract]   [Full Text] [Related]  

  • 27. Interaction of indomethacin and ibuprofen with lithium in manic patients under a steady-state lithium level.
    Ragheb M; Ban TA; Buchanan D; Frolich JC
    J Clin Psychiatry; 1980 Nov; 41(11):397-8. PubMed ID: 7440513
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bioavailability, food effect and tolerability of S-naproxen betainate sodium salt monohydrate in steady state.
    Marzo A; Dal Bo L; Wool C; Cerutti R
    Arzneimittelforschung; 1998 Sep; 48(9):935-40. PubMed ID: 9793622
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Appropriateness of therapeutic drug monitoring for lithium.
    Ratanajamit C; Soorapan S; Doang-ngern T; Waenwaisart W; Suwanchavalit L; Suwansiri S; Jantasaro S; Yanate I
    J Med Assoc Thai; 2006 Nov; 89(11):1954-60. PubMed ID: 17205880
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lymphadenopathy with sulindac therapy.
    Hoffman HS; Rudnicki RD
    Conn Med; 1988 Feb; 52(2):115-6. PubMed ID: 3345662
    [No Abstract]   [Full Text] [Related]  

  • 31. Sulindac-induced Stevens-Johnson syndrome: report of 3 cases.
    Husain Z; Runge LA; Jabbs JM; Hyla JA
    J Rheumatol; 1981; 8(1):176-9. PubMed ID: 7218253
    [No Abstract]   [Full Text] [Related]  

  • 32. Sulindac in the treatment of acute gout arthritis.
    Karachalios GN; Donas G
    Int J Tissue React; 1982; 4(4):297-9. PubMed ID: 7169301
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypertensive reaction with sulindac.
    Easton PA; Koval A
    Can Med Assoc J; 1980 Jun; 122(11):1273-4. PubMed ID: 7388724
    [No Abstract]   [Full Text] [Related]  

  • 34. Calcitonin decreases lithium plasma levels in man. Preliminary report.
    Passiu G; Bocchetta A; Martinelli V; Garau P; Del Zompo M; Mathieu A
    Int J Clin Pharmacol Res; 1998; 18(4):179-81. PubMed ID: 10052028
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nephrotic syndrome associated with sulindac.
    Lomvardias S; Pinn VW; Wadhwa ML; Koshy KM; Heller M
    N Engl J Med; 1981 Feb; 304(7):424. PubMed ID: 7453761
    [No Abstract]   [Full Text] [Related]  

  • 36. Hypersensitivity reaction to sulindac (Clinoril).
    Lending RE; Gall EP; Buchsbaum HW; Foote RA
    Arch Intern Med; 1984 Nov; 144(11):2259-60. PubMed ID: 6093724
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sulindac (Clinoril) and cholestatic jaundice.
    McIndoe GA; Menzies KW; Reddy J
    N Z Med J; 1981 Dec; 94(697):430-1. PubMed ID: 6950284
    [No Abstract]   [Full Text] [Related]  

  • 38. [Development toward segmental and focal hyalinosis of a nephrotic syndrome with minimal glomerular lesions in a patient treated with sulindac].
    Pagniez D; Gosset D; Hardouin P; Noël C; Delvallez L; Dequiedt P
    Nephrologie; 1988; 9(2):90-1. PubMed ID: 2459625
    [No Abstract]   [Full Text] [Related]  

  • 39. Peripheral neuropathy after concomitant dimethyl sulfoxide use and sulindac therapy.
    Reinstein L; Mahon R; Russo GL
    Arch Phys Med Rehabil; 1982 Nov; 63(11):581-4. PubMed ID: 6291491
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cholestatic jaundice caused by sulindac.
    Giroux Y; Moreau M; Kass TG
    Can J Surg; 1982 May; 25(3):334-5. PubMed ID: 7083082
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.